Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1990 Jul;66(777):536–538. doi: 10.1136/pgmj.66.777.536

Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity.

G S Conway 1, H S Jacobs 1
PMCID: PMC2429633  PMID: 2217009

Abstract

Fasting and stimulated insulin concentrations in four patients with acanthosis nigricans and polycystic ovary syndrome were compared with four patients, matched for weight and ovarian morphology, without acanthosis. The median fasting serum insulin concentrations were 114.2 and 25.1 mU/l in the respective groups (P = 0.02). One additional patient was investigated before and after an 18% increase in weight which resulted in a 170% increase in fasting insulin concentrations and the development of acanthosis nigricans. These observations suggest that there is variation between individuals in the degree of obesity that results in the development of acanthosis and that obese patients with this skin condition represent the severe end of the spectrum of the polycystic ovary syndrome.

Full text

PDF
536

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bar R. S., Muggeo M., Roth J., Kahn C. R., Havrankova J., Imperato-McGinley J. Insulin resistance, acanthosis nigricans, and normal insulin receptors in a young woman: evidence for a postreceptor defect. J Clin Endocrinol Metab. 1978 Sep;47(3):620–625. doi: 10.1210/jcem-47-3-620. [DOI] [PubMed] [Google Scholar]
  2. Barbieri R. L., Ryan K. J. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol. 1983 Sep 1;147(1):90–101. doi: 10.1016/0002-9378(83)90091-1. [DOI] [PubMed] [Google Scholar]
  3. Barbieri R. L., Smith S., Ryan K. J. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril. 1988 Aug;50(2):197–212. doi: 10.1016/s0015-0282(16)60060-2. [DOI] [PubMed] [Google Scholar]
  4. Chang R. J., Nakamura R. M., Judd H. L., Kaplan S. A. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1983 Aug;57(2):356–359. doi: 10.1210/jcem-57-2-356. [DOI] [PubMed] [Google Scholar]
  5. Conway G. S., Honour J. W., Jacobs H. S. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 1989 Apr;30(4):459–470. doi: 10.1111/j.1365-2265.1989.tb00446.x. [DOI] [PubMed] [Google Scholar]
  6. Flier J. S., Eastman R. C., Minaker K. L., Matteson D., Rowe J. W. Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the type A and B syndromes. Diabetes. 1985 Feb;34(2):101–107. doi: 10.2337/diab.34.2.101. [DOI] [PubMed] [Google Scholar]
  7. Flier J. S. Metabolic importance of acanthosis nigricans. Arch Dermatol. 1985 Feb;121(2):193–194. [PubMed] [Google Scholar]
  8. Geffner M. E., Golde D. W. Selective insulin action on skin, ovary, and heart in insulin-resistant states. Diabetes Care. 1988 Jun;11(6):500–505. doi: 10.2337/diacare.11.6.500. [DOI] [PubMed] [Google Scholar]
  9. Grigorescu F., Flier J. S., Kahn C. R. Characterization of binding and phosphorylation defects of erythrocyte insulin receptors in the type A syndrome of insulin resistance. Diabetes. 1986 Feb;35(2):127–138. doi: 10.2337/diab.35.2.127. [DOI] [PubMed] [Google Scholar]
  10. Kahn C. R., Flier J. S., Bar R. S., Archer J. A., Gorden P., Martin M. M., Roth J. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med. 1976 Apr 1;294(14):739–745. doi: 10.1056/NEJM197604012941401. [DOI] [PubMed] [Google Scholar]
  11. Leme C. E., Wajchenberg B. L., Lerário A. C., Goldman J., Borges J. L. Acanthosis nigricans, hirsutism, insulin resistance and insulin receptor defect. Clin Endocrinol (Oxf) 1982 Jul 1;17(1):43–49. doi: 10.1111/j.1365-2265.1982.tb02632.x. [DOI] [PubMed] [Google Scholar]
  12. Matsuoka L. Y., Wortsman J., Gavin J. R., Goldman J. Spectrum of endocrine abnormalities associated with acanthosis nigricans. Am J Med. 1987 Oct;83(4):719–725. doi: 10.1016/0002-9343(87)90903-x. [DOI] [PubMed] [Google Scholar]
  13. Peters E. J., Stuart C. A., Prince M. J. Acanthosis nigricans and obesity: acquired and intrinsic defects in insulin action. Metabolism. 1986 Sep;35(9):807–813. doi: 10.1016/0026-0495(86)90220-9. [DOI] [PubMed] [Google Scholar]
  14. Stuart C. A., Peters E. J., Prince M. J., Richards G., Cavallo A., Meyer W. J., 3rd Insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess. Metabolism. 1986 Mar;35(3):197–205. doi: 10.1016/0026-0495(86)90201-5. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES